Gemcitabine (CAS 95058-81-4) Market, Global Outlook and Forecast 2022-2028
Gemcitabine (CAS 95058-81-4), C9H11F2N3O4, the formula weight is 263.2, and its form is white to yellow powder.
This report contains market size and forecasts of Gemcitabine (CAS 95058-81-4) in global, including the following market information:
Global Gemcitabine (CAS 95058-81-4) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gemcitabine (CAS 95058-81-4) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Gemcitabine (CAS 95058-81-4) companies in 2021 (%)
The global Gemcitabine (CAS 95058-81-4) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1g/Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gemcitabine (CAS 95058-81-4) include Lilly France, Hansoh Pharma, Hisun Pharma, Pude Pharma, Qilu Pharma, Jari Pharma, HPGC, Yibantian Pharma and Actavis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gemcitabine (CAS 95058-81-4) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gemcitabine (CAS 95058-81-4) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, by Type, 2021 (%)
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, by Application, 2021 (%)
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Gemcitabine (CAS 95058-81-4) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gemcitabine (CAS 95058-81-4) revenues share in global market, 2021 (%)
Key companies Gemcitabine (CAS 95058-81-4) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Gemcitabine (CAS 95058-81-4) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Gemcitabine (CAS 95058-81-4) in global, including the following market information:
Global Gemcitabine (CAS 95058-81-4) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gemcitabine (CAS 95058-81-4) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Gemcitabine (CAS 95058-81-4) companies in 2021 (%)
The global Gemcitabine (CAS 95058-81-4) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1g/Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gemcitabine (CAS 95058-81-4) include Lilly France, Hansoh Pharma, Hisun Pharma, Pude Pharma, Qilu Pharma, Jari Pharma, HPGC, Yibantian Pharma and Actavis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gemcitabine (CAS 95058-81-4) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gemcitabine (CAS 95058-81-4) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, by Type, 2021 (%)
- 1g/Vial
- 200mg/Vial
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Gemcitabine (CAS 95058-81-4) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Gemcitabine (CAS 95058-81-4) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gemcitabine (CAS 95058-81-4) revenues share in global market, 2021 (%)
Key companies Gemcitabine (CAS 95058-81-4) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Gemcitabine (CAS 95058-81-4) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Lilly France
- Hansoh Pharma
- Hisun Pharma
- Pude Pharma
- Qilu Pharma
- Jari Pharma
- HPGC
- Yibantian Pharma
- Actavis
- Accord Healthcare
- Mylan
- Novartis
- Salius Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Gemcitabine (CAS 95058-81-4) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gemcitabine (CAS 95058-81-4) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GEMCITABINE (CAS 95058-81-4) OVERALL MARKET SIZE
2.1 Global Gemcitabine (CAS 95058-81-4) Market Size: 2021 VS 2028
2.2 Global Gemcitabine (CAS 95058-81-4) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gemcitabine (CAS 95058-81-4) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gemcitabine (CAS 95058-81-4) Players in Global Market
3.2 Top Global Gemcitabine (CAS 95058-81-4) Companies Ranked by Revenue
3.3 Global Gemcitabine (CAS 95058-81-4) Revenue by Companies
3.4 Global Gemcitabine (CAS 95058-81-4) Sales by Companies
3.5 Global Gemcitabine (CAS 95058-81-4) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gemcitabine (CAS 95058-81-4) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gemcitabine (CAS 95058-81-4) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Players in Global Market
3.8.1 List of Global Tier 1 Gemcitabine (CAS 95058-81-4) Companies
3.8.2 List of Global Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gemcitabine (CAS 95058-81-4) Market Size Markets, 2021 & 2028
4.1.2 1g/Vial
4.1.3 200mg/Vial
4.2 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
4.2.1 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
4.2.2 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
4.2.3 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
4.3 By Type - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
4.3.1 By Type - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
4.3.2 By Type - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
4.3.3 By Type - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
4.4 By Type - Global Gemcitabine (CAS 95058-81-4) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gemcitabine (CAS 95058-81-4) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
5.2.1 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
5.2.2 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
5.2.3 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
5.3 By Application - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
5.3.1 By Application - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
5.3.2 By Application - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
5.3.3 By Application - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
5.4 By Application - Global Gemcitabine (CAS 95058-81-4) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gemcitabine (CAS 95058-81-4) Market Size, 2021 & 2028
6.2 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
6.2.1 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
6.2.2 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
6.2.3 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
6.3 By Region - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
6.3.1 By Region - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
6.3.2 By Region - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
6.3.3 By Region - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.4.2 By Country - North America Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.4.3 US Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.4.4 Canada Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.4.5 Mexico Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.5.2 By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.5.3 Germany Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.4 France Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.5 U.K. Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.6 Italy Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.7 Russia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.8 Nordic Countries Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.9 Benelux Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.6.2 By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.6.3 China Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.4 Japan Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.5 South Korea Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.6 Southeast Asia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.7 India Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.7.2 By Country - South America Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.7.3 Brazil Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.7.4 Argentina Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.8.3 Turkey Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.4 Israel Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.5 Saudi Arabia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.6 UAE Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Lilly France
7.1.1 Lilly France Corporate Summary
7.1.2 Lilly France Business Overview
7.1.3 Lilly France Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.1.4 Lilly France Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.1.5 Lilly France Key News
7.2 Hansoh Pharma
7.2.1 Hansoh Pharma Corporate Summary
7.2.2 Hansoh Pharma Business Overview
7.2.3 Hansoh Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.2.4 Hansoh Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.2.5 Hansoh Pharma Key News
7.3 Hisun Pharma
7.3.1 Hisun Pharma Corporate Summary
7.3.2 Hisun Pharma Business Overview
7.3.3 Hisun Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.3.4 Hisun Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.3.5 Hisun Pharma Key News
7.4 Pude Pharma
7.4.1 Pude Pharma Corporate Summary
7.4.2 Pude Pharma Business Overview
7.4.3 Pude Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.4.4 Pude Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.4.5 Pude Pharma Key News
7.5 Qilu Pharma
7.5.1 Qilu Pharma Corporate Summary
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.5.4 Qilu Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.5.5 Qilu Pharma Key News
7.6 Jari Pharma
7.6.1 Jari Pharma Corporate Summary
7.6.2 Jari Pharma Business Overview
7.6.3 Jari Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.6.4 Jari Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.6.5 Jari Pharma Key News
7.7 HPGC
7.7.1 HPGC Corporate Summary
7.7.2 HPGC Business Overview
7.7.3 HPGC Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.7.4 HPGC Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.7.5 HPGC Key News
7.8 Yibantian Pharma
7.8.1 Yibantian Pharma Corporate Summary
7.8.2 Yibantian Pharma Business Overview
7.8.3 Yibantian Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.8.4 Yibantian Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.8.5 Yibantian Pharma Key News
7.9 Actavis
7.9.1 Actavis Corporate Summary
7.9.2 Actavis Business Overview
7.9.3 Actavis Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.9.4 Actavis Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.9.5 Actavis Key News
7.10 Accord Healthcare
7.10.1 Accord Healthcare Corporate Summary
7.10.2 Accord Healthcare Business Overview
7.10.3 Accord Healthcare Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.10.4 Accord Healthcare Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.10.5 Accord Healthcare Key News
7.11 Mylan
7.11.1 Mylan Corporate Summary
7.11.2 Mylan Gemcitabine (CAS 95058-81-4) Business Overview
7.11.3 Mylan Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.11.4 Mylan Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.11.5 Mylan Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Gemcitabine (CAS 95058-81-4) Business Overview
7.12.3 Novartis Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.12.4 Novartis Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.12.5 Novartis Key News
7.13 Salius Pharma
7.13.1 Salius Pharma Corporate Summary
7.13.2 Salius Pharma Gemcitabine (CAS 95058-81-4) Business Overview
7.13.3 Salius Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.13.4 Salius Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.13.5 Salius Pharma Key News
8 GLOBAL GEMCITABINE (CAS 95058-81-4) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gemcitabine (CAS 95058-81-4) Production Capacity, 2017-2028
8.2 Gemcitabine (CAS 95058-81-4) Production Capacity of Key Manufacturers in Global Market
8.3 Global Gemcitabine (CAS 95058-81-4) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GEMCITABINE (CAS 95058-81-4) SUPPLY CHAIN ANALYSIS
10.1 Gemcitabine (CAS 95058-81-4) Industry Value Chain
10.2 Gemcitabine (CAS 95058-81-4) Upstream Market
10.3 Gemcitabine (CAS 95058-81-4) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gemcitabine (CAS 95058-81-4) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Gemcitabine (CAS 95058-81-4) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gemcitabine (CAS 95058-81-4) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GEMCITABINE (CAS 95058-81-4) OVERALL MARKET SIZE
2.1 Global Gemcitabine (CAS 95058-81-4) Market Size: 2021 VS 2028
2.2 Global Gemcitabine (CAS 95058-81-4) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gemcitabine (CAS 95058-81-4) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Gemcitabine (CAS 95058-81-4) Players in Global Market
3.2 Top Global Gemcitabine (CAS 95058-81-4) Companies Ranked by Revenue
3.3 Global Gemcitabine (CAS 95058-81-4) Revenue by Companies
3.4 Global Gemcitabine (CAS 95058-81-4) Sales by Companies
3.5 Global Gemcitabine (CAS 95058-81-4) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gemcitabine (CAS 95058-81-4) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gemcitabine (CAS 95058-81-4) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Players in Global Market
3.8.1 List of Global Tier 1 Gemcitabine (CAS 95058-81-4) Companies
3.8.2 List of Global Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Gemcitabine (CAS 95058-81-4) Market Size Markets, 2021 & 2028
4.1.2 1g/Vial
4.1.3 200mg/Vial
4.2 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
4.2.1 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
4.2.2 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
4.2.3 By Type - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
4.3 By Type - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
4.3.1 By Type - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
4.3.2 By Type - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
4.3.3 By Type - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
4.4 By Type - Global Gemcitabine (CAS 95058-81-4) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Gemcitabine (CAS 95058-81-4) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
5.2.1 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
5.2.2 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
5.2.3 By Application - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
5.3 By Application - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
5.3.1 By Application - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
5.3.2 By Application - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
5.3.3 By Application - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
5.4 By Application - Global Gemcitabine (CAS 95058-81-4) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Gemcitabine (CAS 95058-81-4) Market Size, 2021 & 2028
6.2 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue & Forecasts
6.2.1 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2022
6.2.2 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue, 2023-2028
6.2.3 By Region - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
6.3 By Region - Global Gemcitabine (CAS 95058-81-4) Sales & Forecasts
6.3.1 By Region - Global Gemcitabine (CAS 95058-81-4) Sales, 2017-2022
6.3.2 By Region - Global Gemcitabine (CAS 95058-81-4) Sales, 2023-2028
6.3.3 By Region - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.4.2 By Country - North America Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.4.3 US Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.4.4 Canada Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.4.5 Mexico Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.5.2 By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.5.3 Germany Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.4 France Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.5 U.K. Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.6 Italy Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.7 Russia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.8 Nordic Countries Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.5.9 Benelux Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.6.2 By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.6.3 China Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.4 Japan Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.5 South Korea Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.6 Southeast Asia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.6.7 India Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.7.2 By Country - South America Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.7.3 Brazil Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.7.4 Argentina Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, 2017-2028
6.8.3 Turkey Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.4 Israel Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.5 Saudi Arabia Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
6.8.6 UAE Gemcitabine (CAS 95058-81-4) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Lilly France
7.1.1 Lilly France Corporate Summary
7.1.2 Lilly France Business Overview
7.1.3 Lilly France Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.1.4 Lilly France Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.1.5 Lilly France Key News
7.2 Hansoh Pharma
7.2.1 Hansoh Pharma Corporate Summary
7.2.2 Hansoh Pharma Business Overview
7.2.3 Hansoh Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.2.4 Hansoh Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.2.5 Hansoh Pharma Key News
7.3 Hisun Pharma
7.3.1 Hisun Pharma Corporate Summary
7.3.2 Hisun Pharma Business Overview
7.3.3 Hisun Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.3.4 Hisun Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.3.5 Hisun Pharma Key News
7.4 Pude Pharma
7.4.1 Pude Pharma Corporate Summary
7.4.2 Pude Pharma Business Overview
7.4.3 Pude Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.4.4 Pude Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.4.5 Pude Pharma Key News
7.5 Qilu Pharma
7.5.1 Qilu Pharma Corporate Summary
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.5.4 Qilu Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.5.5 Qilu Pharma Key News
7.6 Jari Pharma
7.6.1 Jari Pharma Corporate Summary
7.6.2 Jari Pharma Business Overview
7.6.3 Jari Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.6.4 Jari Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.6.5 Jari Pharma Key News
7.7 HPGC
7.7.1 HPGC Corporate Summary
7.7.2 HPGC Business Overview
7.7.3 HPGC Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.7.4 HPGC Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.7.5 HPGC Key News
7.8 Yibantian Pharma
7.8.1 Yibantian Pharma Corporate Summary
7.8.2 Yibantian Pharma Business Overview
7.8.3 Yibantian Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.8.4 Yibantian Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.8.5 Yibantian Pharma Key News
7.9 Actavis
7.9.1 Actavis Corporate Summary
7.9.2 Actavis Business Overview
7.9.3 Actavis Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.9.4 Actavis Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.9.5 Actavis Key News
7.10 Accord Healthcare
7.10.1 Accord Healthcare Corporate Summary
7.10.2 Accord Healthcare Business Overview
7.10.3 Accord Healthcare Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.10.4 Accord Healthcare Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.10.5 Accord Healthcare Key News
7.11 Mylan
7.11.1 Mylan Corporate Summary
7.11.2 Mylan Gemcitabine (CAS 95058-81-4) Business Overview
7.11.3 Mylan Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.11.4 Mylan Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.11.5 Mylan Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Gemcitabine (CAS 95058-81-4) Business Overview
7.12.3 Novartis Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.12.4 Novartis Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.12.5 Novartis Key News
7.13 Salius Pharma
7.13.1 Salius Pharma Corporate Summary
7.13.2 Salius Pharma Gemcitabine (CAS 95058-81-4) Business Overview
7.13.3 Salius Pharma Gemcitabine (CAS 95058-81-4) Major Product Offerings
7.13.4 Salius Pharma Gemcitabine (CAS 95058-81-4) Sales and Revenue in Global (2017-2022)
7.13.5 Salius Pharma Key News
8 GLOBAL GEMCITABINE (CAS 95058-81-4) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Gemcitabine (CAS 95058-81-4) Production Capacity, 2017-2028
8.2 Gemcitabine (CAS 95058-81-4) Production Capacity of Key Manufacturers in Global Market
8.3 Global Gemcitabine (CAS 95058-81-4) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GEMCITABINE (CAS 95058-81-4) SUPPLY CHAIN ANALYSIS
10.1 Gemcitabine (CAS 95058-81-4) Industry Value Chain
10.2 Gemcitabine (CAS 95058-81-4) Upstream Market
10.3 Gemcitabine (CAS 95058-81-4) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gemcitabine (CAS 95058-81-4) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Gemcitabine (CAS 95058-81-4) in Global Market
Table 2. Top Gemcitabine (CAS 95058-81-4) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gemcitabine (CAS 95058-81-4) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gemcitabine (CAS 95058-81-4) Revenue Share by Companies, 2017-2022
Table 5. Global Gemcitabine (CAS 95058-81-4) Sales by Companies, (Kg), 2017-2022
Table 6. Global Gemcitabine (CAS 95058-81-4) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gemcitabine (CAS 95058-81-4) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Gemcitabine (CAS 95058-81-4) Product Type
Table 9. List of Global Tier 1 Gemcitabine (CAS 95058-81-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 15. By Type - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 16. By Application – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 20. By Application - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 21. By Region – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 25. By Region - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 26. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 29. By Country - North America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 30. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 33. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 34. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 37. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 38. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 41. By Country - South America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 46. Lilly France Corporate Summary
Table 47. Lilly France Gemcitabine (CAS 95058-81-4) Product Offerings
Table 48. Lilly France Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Hansoh Pharma Corporate Summary
Table 50. Hansoh Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 51. Hansoh Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Hisun Pharma Corporate Summary
Table 53. Hisun Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 54. Hisun Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Pude Pharma Corporate Summary
Table 56. Pude Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 57. Pude Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Qilu Pharma Corporate Summary
Table 59. Qilu Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 60. Qilu Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Jari Pharma Corporate Summary
Table 62. Jari Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 63. Jari Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. HPGC Corporate Summary
Table 65. HPGC Gemcitabine (CAS 95058-81-4) Product Offerings
Table 66. HPGC Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Yibantian Pharma Corporate Summary
Table 68. Yibantian Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 69. Yibantian Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Actavis Corporate Summary
Table 71. Actavis Gemcitabine (CAS 95058-81-4) Product Offerings
Table 72. Actavis Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Accord Healthcare Corporate Summary
Table 74. Accord Healthcare Gemcitabine (CAS 95058-81-4) Product Offerings
Table 75. Accord Healthcare Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Mylan Corporate Summary
Table 77. Mylan Gemcitabine (CAS 95058-81-4) Product Offerings
Table 78. Mylan Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 79. Novartis Corporate Summary
Table 80. Novartis Gemcitabine (CAS 95058-81-4) Product Offerings
Table 81. Novartis Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 82. Salius Pharma Corporate Summary
Table 83. Salius Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 84. Salius Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 85. Gemcitabine (CAS 95058-81-4) Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 86. Global Gemcitabine (CAS 95058-81-4) Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Gemcitabine (CAS 95058-81-4) Production by Region, 2017-2022 (Kg)
Table 88. Global Gemcitabine (CAS 95058-81-4) Production by Region, 2023-2028 (Kg)
Table 89. Gemcitabine (CAS 95058-81-4) Market Opportunities & Trends in Global Market
Table 90. Gemcitabine (CAS 95058-81-4) Market Drivers in Global Market
Table 91. Gemcitabine (CAS 95058-81-4) Market Restraints in Global Market
Table 92. Gemcitabine (CAS 95058-81-4) Raw Materials
Table 93. Gemcitabine (CAS 95058-81-4) Raw Materials Suppliers in Global Market
Table 94. Typical Gemcitabine (CAS 95058-81-4) Downstream
Table 95. Gemcitabine (CAS 95058-81-4) Downstream Clients in Global Market
Table 96. Gemcitabine (CAS 95058-81-4) Distributors and Sales Agents in Global Market
Table 1. Key Players of Gemcitabine (CAS 95058-81-4) in Global Market
Table 2. Top Gemcitabine (CAS 95058-81-4) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gemcitabine (CAS 95058-81-4) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gemcitabine (CAS 95058-81-4) Revenue Share by Companies, 2017-2022
Table 5. Global Gemcitabine (CAS 95058-81-4) Sales by Companies, (Kg), 2017-2022
Table 6. Global Gemcitabine (CAS 95058-81-4) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gemcitabine (CAS 95058-81-4) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Gemcitabine (CAS 95058-81-4) Product Type
Table 9. List of Global Tier 1 Gemcitabine (CAS 95058-81-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gemcitabine (CAS 95058-81-4) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 15. By Type - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 16. By Application – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 20. By Application - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 21. By Region – Global Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2017-2022
Table 25. By Region - Global Gemcitabine (CAS 95058-81-4) Sales (Kg), 2023-2028
Table 26. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 29. By Country - North America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 30. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 33. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 34. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 37. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 38. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 41. By Country - South America Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales, (Kg), 2023-2028
Table 46. Lilly France Corporate Summary
Table 47. Lilly France Gemcitabine (CAS 95058-81-4) Product Offerings
Table 48. Lilly France Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Hansoh Pharma Corporate Summary
Table 50. Hansoh Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 51. Hansoh Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Hisun Pharma Corporate Summary
Table 53. Hisun Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 54. Hisun Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Pude Pharma Corporate Summary
Table 56. Pude Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 57. Pude Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Qilu Pharma Corporate Summary
Table 59. Qilu Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 60. Qilu Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Jari Pharma Corporate Summary
Table 62. Jari Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 63. Jari Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. HPGC Corporate Summary
Table 65. HPGC Gemcitabine (CAS 95058-81-4) Product Offerings
Table 66. HPGC Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Yibantian Pharma Corporate Summary
Table 68. Yibantian Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 69. Yibantian Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Actavis Corporate Summary
Table 71. Actavis Gemcitabine (CAS 95058-81-4) Product Offerings
Table 72. Actavis Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Accord Healthcare Corporate Summary
Table 74. Accord Healthcare Gemcitabine (CAS 95058-81-4) Product Offerings
Table 75. Accord Healthcare Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Mylan Corporate Summary
Table 77. Mylan Gemcitabine (CAS 95058-81-4) Product Offerings
Table 78. Mylan Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 79. Novartis Corporate Summary
Table 80. Novartis Gemcitabine (CAS 95058-81-4) Product Offerings
Table 81. Novartis Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 82. Salius Pharma Corporate Summary
Table 83. Salius Pharma Gemcitabine (CAS 95058-81-4) Product Offerings
Table 84. Salius Pharma Gemcitabine (CAS 95058-81-4) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 85. Gemcitabine (CAS 95058-81-4) Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 86. Global Gemcitabine (CAS 95058-81-4) Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Gemcitabine (CAS 95058-81-4) Production by Region, 2017-2022 (Kg)
Table 88. Global Gemcitabine (CAS 95058-81-4) Production by Region, 2023-2028 (Kg)
Table 89. Gemcitabine (CAS 95058-81-4) Market Opportunities & Trends in Global Market
Table 90. Gemcitabine (CAS 95058-81-4) Market Drivers in Global Market
Table 91. Gemcitabine (CAS 95058-81-4) Market Restraints in Global Market
Table 92. Gemcitabine (CAS 95058-81-4) Raw Materials
Table 93. Gemcitabine (CAS 95058-81-4) Raw Materials Suppliers in Global Market
Table 94. Typical Gemcitabine (CAS 95058-81-4) Downstream
Table 95. Gemcitabine (CAS 95058-81-4) Downstream Clients in Global Market
Table 96. Gemcitabine (CAS 95058-81-4) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Gemcitabine (CAS 95058-81-4) Segment by Type
Figure 2. Gemcitabine (CAS 95058-81-4) Segment by Application
Figure 3. Global Gemcitabine (CAS 95058-81-4) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gemcitabine (CAS 95058-81-4) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028 (US$, Mn)
Figure 7. Gemcitabine (CAS 95058-81-4) Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Gemcitabine (CAS 95058-81-4) Revenue in 2021
Figure 9. By Type - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 10. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gemcitabine (CAS 95058-81-4) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 13. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gemcitabine (CAS 95058-81-4) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 16. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 19. US Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 24. Germany Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 25. France Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 33. China Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 37. India Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 40. Brazil Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 44. Turkey Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gemcitabine (CAS 95058-81-4) Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Gemcitabine (CAS 95058-81-4) by Region, 2021 VS 2028
Figure 50. Gemcitabine (CAS 95058-81-4) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Gemcitabine (CAS 95058-81-4) Segment by Type
Figure 2. Gemcitabine (CAS 95058-81-4) Segment by Application
Figure 3. Global Gemcitabine (CAS 95058-81-4) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gemcitabine (CAS 95058-81-4) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gemcitabine (CAS 95058-81-4) Revenue, 2017-2028 (US$, Mn)
Figure 7. Gemcitabine (CAS 95058-81-4) Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Gemcitabine (CAS 95058-81-4) Revenue in 2021
Figure 9. By Type - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 10. By Type - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gemcitabine (CAS 95058-81-4) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 13. By Application - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gemcitabine (CAS 95058-81-4) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 16. By Region - Global Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 19. US Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 24. Germany Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 25. France Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 33. China Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 37. India Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 40. Brazil Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gemcitabine (CAS 95058-81-4) Sales Market Share, 2017-2028
Figure 44. Turkey Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gemcitabine (CAS 95058-81-4) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gemcitabine (CAS 95058-81-4) Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Gemcitabine (CAS 95058-81-4) by Region, 2021 VS 2028
Figure 50. Gemcitabine (CAS 95058-81-4) Industry Value Chain
Figure 51. Marketing Channels
